Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionWealth Alliance
Latest Disclosed Ownership3,248 shares
Latest Disclosed Value $ 496,134
Wealth Alliance reports 8.82% decrease in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 14, 2026 - Wealth Alliance filed a 13F-HR form disclosing ownership of 3,248 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $496,132 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 3,562 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -8.82% during the quarter. The current value of the position is $466,608 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 3,248 -314 -8.82 496 1.02 0.0490
2026-02-13 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,562 -61 -1.68 491 5.82 0.0481
2025-11-07 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 3,623 56 1.57 465 7.66 0.0478
2025-08-08 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 3,567 -9 -0.25 432 8.29 0.0482
2025-05-05 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 3,576 149 4.35 399 19.52 0.0482
2025-02-03 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,427 -94 -2.67 333 -17.57 0.0399
2024-11-04 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 3,521 -162 -4.40 405 3.06 0.0484
2024-08-09 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 3,683 191 5.47 392 16.32 0.0506
2024-05-10 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 3,492 72 2.11 338 -2.32 0.0443
2024-01-30 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,420 -177 -4.92 345 -5.74 0.0484
2023-11-09 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 3,597 -392 -9.83 366 -8.96 0.0578
2023-08-02 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 3,989 -112 -2.73 403 6.63 0.0602
2023-05-11 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 4,101 -17 -0.41 377 1.07 0.0611
2023-02-13 2022-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 4,118 -224 -5.16 374 13.03 0.0663
2022-11-14 2022-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 4,342 921 26.92 330 14.19 0.0651
2022-10-11 2022-06-30 13F/A-1 NOVARTIS AG SPONSORED ADR ADR 66987V109 3,421 3,421 289 0.0555
2022-02-14 2021-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 0 -7,175 -100.00 0 -100.00
2021-11-12 2021-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 7,175 253 3.66 586 -7.28 0.1316
2021-08-16 2021-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 6,922 670 10.72 632 18.35 0.1488
2021-05-18 2021-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 6,252 -4,489 -41.79 534 -47.39 0.1496
2021-02-11 2020-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 10,741 -689 -6.03 1,015 2.11 0.2991
2020-12-01 2020-09-30 13F/A-1 NOVARTIS AG SPONSORED ADR ADR 66987V109 11,430 -1,572 -12.09 994 -12.50 0.3573
2020-11-13 2020-09-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 11,430 -1,572 994 292,370.9994
2020-08-14 2020-06-30 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 13,002 4,807 58.66 1,136 68.05 0.4488
2020-05-15 2020-03-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 8,195 8,195 676 0.3645
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.